That the FDA took five years to approve NVS/MNTA’s ANDA and has been reviewing Teva’s and Amphastar’s ANDAs for almost eight years is, IMO, prima facie evidence that the “junk” in Lovenox matters.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”